Oramed Pharmaceuticals Inc.
ORMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001176309
In the last 90 days, Oramed Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 84 institutions reported holding it in 13F filings for Q2 2026, worth $80.7M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Oramed Pharmaceuticals Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 47 | 47 | 0 |
| Shares | 7.25M | 9.21M | +1.96M (+27.0%) |
| Value | $16.3M | $24.3M | +$8.00M (+49.0%) |
New holders (5)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Aquamarine Financial (Cayman) Ltd | 1,973,057 | $5.21M | 0.53% |
| XTX Topco Ltd | 23,885 | $63.1K | 0.00% |
| FMR LLC | 500 | $1.32K | 0.00% |
| JPMorgan Chase & Co | 170 | $449 | 0.00% |
| Citigroup Inc | 4 | $11 | 0.00% |
Sold out (5)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Peapod Lane Capital LLC | 84,779 | $190.7K |
| State Street Corp | 66,451 | $149.5K |
| Raymond James Financial Inc | 3,576 | $8.05K |
| National Bank of Canada | 2,000 | $4.38K |
| Beacon Capital Management, LLC | 219 | $493 |